NCT02050321 2018-12-26
A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma
University of Arizona
Phase 2 Terminated
University of Arizona
Alliance for Clinical Trials in Oncology
University of Pittsburgh
Mayo Clinic